<DOC>
	<DOCNO>NCT02556138</DOCNO>
	<brief_summary>The purpose study determine whether ORBERA Intragastric Balloon safe effective mean weight loss improve metabolic disease patient cirrhosis require liver transplantation .</brief_summary>
	<brief_title>Endoscopic Intragastric Balloon Placement Weight Loss Liver Transplant Waitlist Candidates</brief_title>
	<detailed_description />
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>Adults ( &gt; 18 year ) endstage liver disease list liver transplant Have fail noninvasive approach weight loss actively list transplant ( require 2 clinical return visit without weight loss &gt; 5 kg ) Body Mass Index ( BMI ) &gt; 35 Age &gt; 18 year Negative pregnancy test female able get pregnant childbearing age A previous history gastric bariatric surgery Current recent ( within 6 month ) gastric duodenal ulcer Moderate severe Portal hypertension define portal gastropathy grade &gt; = moderate/severe , gastric varix , esophageal varix grade &gt; = moderate/large ( Patients varix obliterate may include ) . Calculated MELD score &gt; 25 child score &gt; 10 The presence one gastric balloon time Any inflammatory disease gastrointestinal tract include esophagitis , gastric ulceration , duodenal ulceration , cancer specific inflammation Crohn 's disease . A large hiatal hernia &gt; 5 cm hernia â‰¤5 cm associate severe intractable gastroesophageal reflux symptom . A structural abnormality esophagus pharynx stricture diverticulum could impede passage delivery catheter and/or endoscope . Achalasia severe motility disorder may pose safety risk removal device . Gastric mass Severe coagulopathy Patients know suspected allergic reaction material contain ORBERA . Serious uncontrolled psychiatric illness disorder could compromise patient understand compliance follow visit removal device 6 month . Alcoholism drug addiction Patients unable unwilling take prescribed proton pump inhibitor medication duration device implant Patients unwilling participate establish medicallysupervised diet behavior modification program , routine medical followup . Patients receive aspirin , antiinflammatory agent , anticoagulant gastric irritant , medical supervision .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Intragastric Balloon</keyword>
	<keyword>ORBERA Intragastric Balloon</keyword>
	<keyword>Weight Loss</keyword>
	<keyword>BMI &gt; 35</keyword>
</DOC>